<DOC>
	<DOCNO>NCT01412801</DOCNO>
	<brief_summary>The study compare magnitude antibody response safety GBS Trivalent Vaccine HIV positive HIV negative pregnant woman offspring . In addition study investigate maternal fetal transfer antibody induce investigational vaccine .</brief_summary>
	<brief_title>Magnitude Antibody Response Safety GBS Trivalent Vaccine HIV Positive HIV Negative Pregnant Women Their Offsprings</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Positive Bacterial Infections</mesh_term>
	<mesh_term>Streptococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Pregnant woman 1840 year age 2435 week gestation Women HIVneg HIVpos WHO stage I II disease CD4+ count &gt; 50 cells/µL Women CD4+ count ≤ 50 cells/µL Women HIVpos WHO stage III IV disease , history severe allergic reaction previous vaccination</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Group B streptococcus</keyword>
	<keyword>GBS</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Prevention group B streptococcus infection</keyword>
</DOC>